82 related articles for article (PubMed ID: 10979205)
1. Repression of aberrant splicing in human beta-globin pre-mRNA with HbE mutation by antisense oligoribonucleotide or splicing factor SF2/ASF.
Shirohzu H; Yamaza H; Fukumaki Y
Int J Hematol; 2000 Jul; 72(1):28-33. PubMed ID: 10979205
[TBL] [Abstract][Full Text] [Related]
2. Reversal of aberrant splicing of beta-thalassemia allele by antisense RNA in vitro and in vivo.
Zeng Y; Gu X; Chen Y; Gong L; Ren Z; Huang S
Chin Med J (Engl); 1999 Feb; 112(2):107-11. PubMed ID: 11593572
[TBL] [Abstract][Full Text] [Related]
3. Correction of aberrant pre-mRNA splicing by antisense oligonucleotides in beta-thalassemia Egyptian patients with IVSI-110 mutation.
El-Beshlawy A; Mostafa A; Youssry I; Gabr H; Mansour IM; El-Tablawy M; Aziz M; Hussein IR
J Pediatr Hematol Oncol; 2008 Apr; 30(4):281-4. PubMed ID: 18391696
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of globin gene expression in different thalassaemia disorders: individual variation of β(E) pre-mRNA splicing determine disease severity.
Tubsuwan A; Munkongdee T; Jearawiriyapaisarn N; Boonchoy C; Winichagoon P; Fucharoen S; Svasti S
Br J Haematol; 2011 Sep; 154(5):635-43. PubMed ID: 21732929
[TBL] [Abstract][Full Text] [Related]
5. [Repair of the splicing defect of thalassemic allele beta IVS-2-654 C-->T in cultured human erythroid cells by antisense RNA].
Gu X; Gong L; Zhang W
Zhonghua Yi Xue Za Zhi; 1997 Nov; 77(11):815-8. PubMed ID: 9772473
[TBL] [Abstract][Full Text] [Related]
6. Engineered U7 snRNA mediates sustained splicing correction in erythroid cells from β-thalassemia/HbE patients.
Preedagasamzin S; Nualkaew T; Pongrujikorn T; Jinawath N; Kole R; Fucharoen S; Jearawiriyapaisarn N; Svasti S
Biochem Biophys Res Commun; 2018 Apr; 499(1):86-92. PubMed ID: 29550480
[TBL] [Abstract][Full Text] [Related]
7. Role of alternatively spliced beta E-globin mRNA on clinical severity of beta-thalassemia/hemoglobin E disease.
Winichagoon P; Fucharoen S; Wilairat P; Chihara K; Fukumaki Y
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():241-5. PubMed ID: 8629114
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of thalassemia in southeast Asia.
Winichagoon P; Fucharoen S; Wilairat P; Fukumaki Y
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():235-40. PubMed ID: 8629113
[TBL] [Abstract][Full Text] [Related]
9. A deep intronic mutation in FGB creates a consensus exonic splicing enhancer motif that results in afibrinogenemia caused by aberrant mRNA splicing, which can be corrected in vitro with antisense oligonucleotide treatment.
Davis RL; Homer VM; George PM; Brennan SO
Hum Mutat; 2009 Feb; 30(2):221-7. PubMed ID: 18853456
[TBL] [Abstract][Full Text] [Related]
10. Repair of a splicing defect in erythroid cells from patients with beta-thalassemia/HbE disorder.
Suwanmanee T; Sierakowska H; Fucharoen S; Kole R
Mol Ther; 2002 Dec; 6(6):718-26. PubMed ID: 12498768
[TBL] [Abstract][Full Text] [Related]
11. Restoration of correct β
Nualkaew T; Jearawiriyapaisarn N; Hongeng S; Fucharoen S; Kole R; Svasti S
Sci Rep; 2019 May; 9(1):7672. PubMed ID: 31113996
[TBL] [Abstract][Full Text] [Related]
12. Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides.
Sierakowska H; Sambade MJ; Agrawal S; Kole R
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12840-4. PubMed ID: 8917506
[TBL] [Abstract][Full Text] [Related]
13. A humanized BAC transgenic/knockout mouse model for HbE/beta-thalassemia.
Jamsai D; Zaibak F; Vadolas J; Voullaire L; Fowler KJ; Gazeas S; Peters H; Fucharoen S; Williamson R; Ioannou PA
Genomics; 2006 Sep; 88(3):309-15. PubMed ID: 16631345
[TBL] [Abstract][Full Text] [Related]
14. "Silent" nucleotide substitution in codon 24 of a beta+ thalassemia globin gene activates splice site in coding sequence RNA.
Humphries RK; Ley T; Goldsmith ME; Kantor JA; Cline AC; Nienhuis AW
Prog Clin Biol Res; 1983; 134():123-6. PubMed ID: 6664994
[TBL] [Abstract][Full Text] [Related]
15. Beta-globin gene cluster polymorphisms are strongly associated with severity of HbE/beta(0)-thalassemia.
Ma Q; Abel K; Sripichai O; Whitacre J; Angkachatchai V; Makarasara W; Winichagoon P; Fucharoen S; Braun A; Farrer LA
Clin Genet; 2007 Dec; 72(6):497-505. PubMed ID: 17894837
[TBL] [Abstract][Full Text] [Related]
16. High-level expression of hemoglobin A in human thalassemic erythroid progenitor cells following lentiviral vector delivery of an antisense snRNA.
Vacek MM; Ma H; Gemignani F; Lacerra G; Kafri T; Kole R
Blood; 2003 Jan; 101(1):104-11. PubMed ID: 12393543
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous mutation of the hemoglobin Leiden (beta 6 or 7 Glu-->0) in a Thai girl.
Sanguansermsri P; Shimbhu D; Wongvilairat R; Pimsorn C; Sanguansermsri T
Haematologica; 2003 Dec; 88(12):ECR35. PubMed ID: 14688008
[TBL] [Abstract][Full Text] [Related]
18. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
[TBL] [Abstract][Full Text] [Related]
19. Restoration of correct splicing of thalassemic beta-globin pre-mRNA by modified U1 snRNAs.
Gorman L; Mercatante DR; Kole R
J Biol Chem; 2000 Nov; 275(46):35914-9. PubMed ID: 10969081
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotides and RNAs as modulators of pre-mRNA splicing.
Sierakowska H; Gorman L; Kang SH; Kole R
Methods Enzymol; 2000; 313():506-21. PubMed ID: 10595376
[No Abstract] [Full Text] [Related]
[Next] [New Search]
